Global Erectile Dysfunction Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 101

Report ID: 4093

The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels.
The ED drugs segment led the market and accounted for almost 80% of the market share in terms of revenue.
In terms of geography, the Americas dominated the global erectile dysfunction market and is expected to hold close to 50% of the market share.
In 2018, the global Erectile Dysfunction market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Erectile Dysfunction status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Erectile Dysfunction development in United States, Europe and China.

The key players covered in this study
Eli Lilly
Pfizer
Bayer
Boston Scientific
Coloplast
Apricus Biosciences
Cristalia Produtos Quimicos Farmaceuticos
Dong-A Socio
Endo Pharmaceuticals
Futura Medical
Meda Pharmaceuticals
Promedon
SK Chemical
Teva Pharmaceuticals
Vivus
Zephyr Surgical Implants (ZSI)

Market segment by Type, the product can be split into
ED Drugs
ED Devices

Market segment by Application, split into
Congenital Patients
Pathological Patients

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Erectile Dysfunction status, future forecast, growth opportunity, key market and key players.
To present the Erectile Dysfunction development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Erectile Dysfunction are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Erectile Dysfunction Market Size Growth Rate by Type (2014-2025)
1.4.2 ED Drugs
1.4.3 ED Devices
1.5 Market by Application
1.5.1 Global Erectile Dysfunction Market Share by Application (2014-2025)
1.5.2 Congenital Patients
1.5.3 Pathological Patients
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Erectile Dysfunction Market Size
2.2 Erectile Dysfunction Growth Trends by Regions
2.2.1 Erectile Dysfunction Market Size by Regions (2014-2025)
2.2.2 Erectile Dysfunction Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Erectile Dysfunction Market Size by Manufacturers
3.1.1 Global Erectile Dysfunction Revenue by Manufacturers (2014-2019)
3.1.2 Global Erectile Dysfunction Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Erectile Dysfunction Market Concentration Ratio (CR5 and HHI)
3.2 Erectile Dysfunction Key Players Head office and Area Served
3.3 Key Players Erectile Dysfunction Product/Solution/Service
3.4 Date of Enter into Erectile Dysfunction Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Erectile Dysfunction Market Size by Type (2014-2019)
4.2 Global Erectile Dysfunction Market Size by Application (2014-2019)

5 United States
5.1 United States Erectile Dysfunction Market Size (2014-2019)
5.2 Erectile Dysfunction Key Players in United States
5.3 United States Erectile Dysfunction Market Size by Type
5.4 United States Erectile Dysfunction Market Size by Application

6 Europe
6.1 Europe Erectile Dysfunction Market Size (2014-2019)
6.2 Erectile Dysfunction Key Players in Europe
6.3 Europe Erectile Dysfunction Market Size by Type
6.4 Europe Erectile Dysfunction Market Size by Application

7 China
7.1 China Erectile Dysfunction Market Size (2014-2019)
7.2 Erectile Dysfunction Key Players in China
7.3 China Erectile Dysfunction Market Size by Type
7.4 China Erectile Dysfunction Market Size by Application

8 Japan
8.1 Japan Erectile Dysfunction Market Size (2014-2019)
8.2 Erectile Dysfunction Key Players in Japan
8.3 Japan Erectile Dysfunction Market Size by Type
8.4 Japan Erectile Dysfunction Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Erectile Dysfunction Market Size (2014-2019)
9.2 Erectile Dysfunction Key Players in Southeast Asia
9.3 Southeast Asia Erectile Dysfunction Market Size by Type
9.4 Southeast Asia Erectile Dysfunction Market Size by Application

10 India
10.1 India Erectile Dysfunction Market Size (2014-2019)
10.2 Erectile Dysfunction Key Players in India
10.3 India Erectile Dysfunction Market Size by Type
10.4 India Erectile Dysfunction Market Size by Application

11 Central & South America
11.1 Central & South America Erectile Dysfunction Market Size (2014-2019)
11.2 Erectile Dysfunction Key Players in Central & South America
11.3 Central & South America Erectile Dysfunction Market Size by Type
11.4 Central & South America Erectile Dysfunction Market Size by Application

12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Erectile Dysfunction Introduction
12.1.4 Eli Lilly Revenue in Erectile Dysfunction Business (2014-2019)
12.1.5 Eli Lilly Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Erectile Dysfunction Introduction
12.2.4 Pfizer Revenue in Erectile Dysfunction Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Bayer
12.3.1 Bayer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Erectile Dysfunction Introduction
12.3.4 Bayer Revenue in Erectile Dysfunction Business (2014-2019)
12.3.5 Bayer Recent Development
12.4 Boston Scientific
12.4.1 Boston Scientific Company Details
12.4.2 Company Description and Business Overview
12.4.3 Erectile Dysfunction Introduction
12.4.4 Boston Scientific Revenue in Erectile Dysfunction Business (2014-2019)
12.4.5 Boston Scientific Recent Development
12.5 Coloplast
12.5.1 Coloplast Company Details
12.5.2 Company Description and Business Overview
12.5.3 Erectile Dysfunction Introduction
12.5.4 Coloplast Revenue in Erectile Dysfunction Business (2014-2019)
12.5.5 Coloplast Recent Development
12.6 Apricus Biosciences
12.6.1 Apricus Biosciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 Erectile Dysfunction Introduction
12.6.4 Apricus Biosciences Revenue in Erectile Dysfunction Business (2014-2019)
12.6.5 Apricus Biosciences Recent Development
12.7 Cristalia Produtos Quimicos Farmaceuticos
12.7.1 Cristalia Produtos Quimicos Farmaceuticos Company Details
12.7.2 Company Description and Business Overview
12.7.3 Erectile Dysfunction Introduction
12.7.4 Cristalia Produtos Quimicos Farmaceuticos Revenue in Erectile Dysfunction Business (2014-2019)
12.7.5 Cristalia Produtos Quimicos Farmaceuticos Recent Development
12.8 Dong-A Socio
12.8.1 Dong-A Socio Company Details
12.8.2 Company Description and Business Overview
12.8.3 Erectile Dysfunction Introduction
12.8.4 Dong-A Socio Revenue in Erectile Dysfunction Business (2014-2019)
12.8.5 Dong-A Socio Recent Development
12.9 Endo Pharmaceuticals
12.9.1 Endo Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Erectile Dysfunction Introduction
12.9.4 Endo Pharmaceuticals Revenue in Erectile Dysfunction Business (2014-2019)
12.9.5 Endo Pharmaceuticals Recent Development
12.10 Futura Medical
12.10.1 Futura Medical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Erectile Dysfunction Introduction
12.10.4 Futura Medical Revenue in Erectile Dysfunction Business (2014-2019)
12.10.5 Futura Medical Recent Development
12.11 Meda Pharmaceuticals
12.12 Promedon
12.13 SK Chemical
12.14 Teva Pharmaceuticals
12.15 Vivus
12.16 Zephyr Surgical Implants (ZSI)

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details